Concepedia

Michael Tocco

MT

Statistics

Publications

10

Citations

454

H-Index

10

Active since

2001

Affiliations

Sunovion (United States)(Current)

Vion Pharmaceuticals (United States)

Washington University in St. Louis

Michael Tocco is an author at Sunovion (United States) specializing in disability, aphasia neuro-rehabilitation, and rehabilitation.

ORCID

Top concepts

Publications per year

2001–2022

10

Publications

10

Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Zaldy S. Tan, Sudha Seshadri, Alexa Beiser et al. · PubMed · 2003 · 277 citations

Effect of Socioeconomic Status on Aphasia Severity and Recovery

Lisa Tabor Connor, Loraine K. Obler, Michael Tocco et al. · Brain and Language · 2001 · 59 citations

, , +6

The epidemiology of Alzheimer's disease: Laying the foundation for drug design, conduct, and analysis of clinical trials

Kristine Yaffe, Michael Tocco, Ronald C. Petersen et al. · Alzheimer s & Dementia · 2012 · 26 citations · Full text

Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features: <i>Post Hoc</i> Analysis of a Randomized Placebo-Controlled Trial

Manpreet K. Singh, Cynthia Siu, Michael Tocco et al. · Journal of Child and Adolescent Psychopharmacology · 2020 · 18 citations · Full text

Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study

Gregory W. Mattingly, Peter Haddad, Michael Tocco et al. · BMC Psychiatry · 2020 · 17 citations · Full text

1–5 of 10